African Americans, Hospitalization, and Hepatitis C Viremic Positive Donor Kidneys: A Retrospective Study
Creator
Hobby, Andrea D
Advisor
Smith, Coleman
Abstract
Hepatitis C Virus (HCV) infected donor kidneys have increased due to the opioid epidemic and are now used for HCV viremic donor kidney transplants. For the patients who receive the viremic donor kidney, they are treated for HCV postrenal transplant. This study assessed the association between race and hospital readmission post viremic donor kidney transplant. 52 subjects had an HCV viremic donor kidney transplant between 2019 and 2020 and Medstar Georgetown University Hospital. The study was consisted of (58%) African Americans and (69%) were males. A small number of patients already had HCV at transplant. (19%). A 29% were readmitted for an inpatient stay thirty days post-transplant. (15/52 patients). It was found that there is no statically significant difference between African Americans and Non-African Americans who have had an HCV viremic donor kidney transplant.
Description
M.S.
Permanent Link
http://hdl.handle.net/10822/1062662Date Published
2021Subject
Type
Embargo Lift Date
2022-03-23
Publisher
Georgetown University
Extent
29 leaves
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Uniquely South African: Time to Consider Offering HIV-Positive Donor Kidneys to HIV-Infected Renal Failure Patients?
Venter, W.D. Francois; Naicker, Sarala; Dhai, Ames; Fabian, June; Wadee, Shoyab; Britz, Russel; Paget, Graham; Meintjes, Graeme (2008-03)